Evidence map›Paper›PMID 25447298›Full record

ArticleBehavioural brain research2015

Peripherally administered oxytocin modulates latent inhibition in a manner consistent with antipsychotic drugs.

D Feifel, P D Shilling, J Hillman, M Maisel, J Winfield, G Melendez

Abstract read
In one paragraph

Article in Behavioural brain research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

D FeifelDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093, United States. Electronic address: dfeifel@ucsd.edu.
P D ShillingDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093, United States.
J HillmanDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093, United States.
M MaiselDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093, United States.
J WinfieldDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093, United States.
G MelendezDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093, United States.
University of California, San Diego · US

Funding

Neurotensin-1 Receptor as a Therapeutic Target for SchizophreniaR01MH080910 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FEIFEL, DAVID · 2009 to 2013
$1.9M
Oxytocin as a therapeutic target for SchizophreniaR01MH103421 · NIMH · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI FEIFEL, DAVID · 2015 to 2019
$1.8M
NIMH NIH HHS R01 MH080910NIMH NIH HHS R01MH080910NIMH NIH HHS R01 MH103421
6 · The paper itself

Abstract

backgroundPeripherally administered oxytocin (OT) has produced antipsychotic drug (APD)-like effects in animal tests that are predictive of APD efficacy. However, these effects have mainly been demonstrated using animal models of schizophrenia-like deficits in prepulse inhibition (PPI) of the startle reflex. Another schizophrenia-relevant abnormality that is the basis of a predictive animal test for APD efficacy is deficient latent inhibition (LI). LI is the normal suppression of a classically conditioned response when the subject is pre-exposed to the conditioned stimulus (CS) before it is paired with the unconditioned stimulus (UCS). Conditioned taste aversion (CTA), the normal avoidance of ingesting a food or liquid by animals when its taste is associated with an aversive experience, was used to test whether OT facilitates LI consistent with APDs.

methodsBrown Norway rats, known to naturally display attenuated LI, were aversively conditioned on two consecutive exposures to flavored drinking water (0.1% saccharin) by pairing it with malaise-inducing lithium chloride injections. Concurrent with conditioning, rats received subcutaneous OT (0.02, 0.1, 0.5mg/kg) or saline. Some rats were pre-exposed to the flavored water prior to its aversive conditioning (pre-exposed) while others were not (non pre-exposed). Two days after aversive conditioning the amount of flavored water consumed during a 20-min session was recorded.

resultsAs expected, LI, defined as greater consumption by pre-exposed vs. non pre-exposed rats was only weakly exhibited in Brown Norway rats and OT enhanced LI by reducing CTA in pre-exposed rats in a dose-dependent manner, with the 0.02 mg/kg dose producing the strongest effect.

conclusionsThe facilitation of LI by OT is consistent with the effects produced by APDs and provides further support for the notion that OT has therapeutic potential for schizophrenia.

Indexed as

Inhibition, PsychologicalAnalysis of VarianceAnimalsAntipsychotic AgentsAvoidance LearningConditioning, ClassicalDose-Response Relationship, DrugDrug Administration RoutesFood DeprivationLithium ChlorideOxytocinRatsReflex, StartleAntipsychotic AgentsLithium ChlorideOxytocinAnimal modelsAntipsychotic drugsLatent inhibitionOxytocinSchizophrenia

Identifiers

PMID25447298
PMCPMC4382379
OpenAlexW1997522103

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.